Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 29, 2019 09:04 ET | Source: OpGen, Inc.

OpGen Announces Closing of Public Offering of Common Stock

GAITHERSBURG, Md., March 29, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today the closing of its previously announced underwritten public offering of 9 million shares of its...
March 28, 2019 07:30 ET | Source: OpGen, Inc.

OpGen Data Predicting Antibiotic Resistance Published in Antimicrobial Agents and Chemotherapy Journal

GAITHERSBURG, Md., March 28, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today that data supporting prediction of antibiotic resistance using the company’s Acuitas® AMR Gene Panel...
March 26, 2019 09:00 ET | Source: OpGen, Inc.

OpGen Announces Pricing of a $5.4 Million Public Offering of Common Stock

GAITHERSBURG, Md., March 26, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today the pricing of an underwritten public offering of 9 million shares of its common stock at a public...
March 25, 2019 07:30 ET | Source: OpGen, Inc.

OpGen and Merck’s ILÚM Health Solutions to Host Event at VIII International Symposium on Hospital Acquired Infections and Antimicrobial Stewardship

GAITHERSBURG, Md., March 25, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today it will host an event with ILÚM Health Solutions, LLC (“ILÚM”), a wholly owned subsidiary of Merck’s...
February 26, 2019 16:02 ET | Source: OpGen, Inc.

OpGen Reports Fourth Quarter and 2018 Financial Results and Provides Business Update

GAITHERSBURG, Md., Feb. 26, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) today reported financial and operating results for the three and 12 months ended December 31, 2018 and provided a...
February 25, 2019 08:30 ET | Source: OpGen, Inc.

OpGen Appoints R. Don Elsey to Board of Directors

GAITHERSBURG, Md., Feb. 25, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) announces the appointment R. Don Elsey to the company’s board of directors and audit committee, effective February 21,...
February 20, 2019 09:00 ET | Source: OpGen, Inc.

OpGen Announces Date of Fourth Quarter and Fiscal Year 2018 Financial Results Conference Call

GAITHERSBURG, Md., Feb. 20, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) announced today that the Company will report its fourth quarter and fiscal year 2018 financial results after the close...
February 05, 2019 07:30 ET | Source: OpGen, Inc.

OpGen Completes Clinical Trials for its Initial FDA 510(k) Submission

GAITHERSBURG, Md., Feb. 05, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today that it has completed the clinical trials needed to support its 510(k) submission for the detection of...
December 18, 2018 07:30 ET | Source: OpGen, Inc.

OpGen Completes CDC Contract to Develop Clinical Support Mobile-Based Tools for Antimicrobial Stewardship and Infection Control

GAITHERSBURG, Md., Dec. 18, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) today announced that it has provided the final report for completion of the contract from the Centers for Disease...
December 04, 2018 07:30 ET | Source: OpGen, Inc.

OpGen Receives Regulatory Approval to Market Pathogen Identification Products in Colombia

GAITHERSBURG, Md., Dec. 04, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today it has received approval from the Instituto Nacional de Vigilancia de Medicamentos y Alimentos...